Cefuroxime axetil

Cefuroxime axetil
Clinical data
Trade names Zinnat, Ceftin, Ceftum
Synonyms Cefuroxime 1-acetoxyethyl ester
Routes of
administration
Oral, IV, IM
Legal status
Legal status
Pharmacokinetic data
Bioavailability well absorbed
Metabolism Cefuroxime is not metabolized, Axetil is metabolized to acetaldehyde and acetic acid.
Excretion Urine
Identifiers
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
Formula C20H22N4O10S
Molar mass 510.475 g/mol
3D model (JSmol)

Cefuroxime axetil is a second generation oral cephalosporin antibiotic. It was discovered by Glaxo now GlaxoSmithKline and introduced in 1987 as Zinnat.[1] It was approved by FDA on Dec 28, 1987.[2] It is available by GSK as Ceftin in US[3] and Ceftum in India.[4]

It is an acetoxyethyl ester prodrug of cefuroxime which is effective orally.[5] The activity depends on in vivo hydrolysis and release of cefuroxime tablets.

See also

References

  1. "Our history - About GSK". GlaxoSmithKline. Archived from the original on 2011-05-14.
  2. "Cefuroxime Axetil Monograph for Professionals". Drugs.com. Retrieved 2018-04-22.
  3. "Brands". Gsksource.com. 2018-03-22. Retrieved 2018-04-22.
  4. "Our products". GlaxoSmithKline.
  5. Walter Sneader (2005-06-23). Drug Discovery: A History. John Wiley, Chichester, UK. ISBN 0-471-89979-8.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.